ARCT – arcturus therapeutics holdings inc. (US:NASDAQ)
Stock Stats
News
Roth Capital Say Market Pricing Implies Zero Success for Arcturus Therapeutics Holdings Inc. (ARCT) Pipeline Assets [Yahoo! Finance]
Arcturus Therapeutics (NASDAQ:ARCT) was upgraded by analysts at Roth Mkm to a "strong-buy" rating.
Arcturus Therapeutics (NASDAQ:ARCT) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Arcturus Therapeutics (NASDAQ:ARCT) is now covered by analysts at Roth Mkm. They set a "buy" rating on the stock.
1 Under-$10 Stock Set to Surge as Much as 963% in 2026 [Yahoo! Finance]
Form SCHEDULE 13G/A Arcturus Therapeutics Filed by: ARK Investment Management LLC
Form SCHEDULE 13G/A Arcturus Therapeutics Filed by: FEDERATED HERMES, INC.
Form S-3 Arcturus Therapeutics
Form 4 Arcturus Therapeutics For: Dec 17 Filed by: Chivukula Pad
Form 4 Arcturus Therapeutics For: Dec 17 Filed by: Roberts Joseph
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.